HYFT — MindWalk Holdings Corp.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1715925 ·
British Columbia, Canada
Last close
$1.38
Market Cap
$64.84M
52W High
$2.99
52W Low
$0.99
ADV30
177,027
Next earnings
2026-09-14
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jul 2026 | 3,834,000 | 2,246,000 | -6,129,000 | -6,085,000 | 17,323,000 | 7,623,000 | 10,412,000 |
| Apr 2026 | — | — | — | — | — | — | — |
| Jan 2026 | 4,158,000 | 2,464,000 | -3,659,000 | -3,930,000 | 22,987,000 | 14,072,000 | 8,127,000 |
| Oct 2025 | 4,124,000 | 2,662,000 | -2,763,000 | -3,195,000 | 26,102,000 | 16,508,000 | 8,397,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-12,463,000
Investing CF
$13,545,000
Financing CF
$115,000
CapEx
$-398,000
Dividends Paid
—
Buybacks
$-125,000
EPS Diluted TTM
$-0.30
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-142,743,000
Inventory
$492,000
Receivables
$3,582,000
ST Investments
$27,538,000
EBIT TTM
$-15,527,000
Pretax Income TTM
$-15,553,000
Interest Exp TTM
$-1,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$15,558,000
EBITDA
$-13,333,000
Free Cash Flow
$-5,467,625
Enterprise Value
$53,496,420
Total Cash
$11,348,000
Total Debt
$3,526,000
Shares Out
46,987,296
Trailing EPS
$-0.24
Book Value
$0.18
ROE
-85.4%
ROA
-28.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Apr 2026 | 15,558,000 | -14,904,000 | -13,949,000 | 21,376,000 | 9,627,000 | 11,749,000 | -12,463,000 |
| Apr 2025 | 10,626,000 | -15,586,000 | -30,234,000 | 44,441,000 | 20,815,000 | 23,626,000 | -6,410,000 |
| Apr 2024 | 10,279,000 | -17,210,000 | -26,115,000 | 59,988,000 | 24,310,000 | 35,678,000 | -3,184,000 |
| Apr 2023 | 20,665,000 | -25,611,000 | -26,560,000 | 77,813,000 | 20,010,000 | 57,803,000 | -19,833,000 |
Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $1.35 · call volume: 6 · put volume: 29
Expected Move to 2027-02-19:
±$1.57
(116.67%) —
implied range
$-0.22 –
$2.93
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| APLM | Apollomics Inc. | $65.15M | $22.35 | — |
| RNTX | Rein Therapeutics, Inc. | $64.53M | $0.75 | — |
| XBIT | XBiotech Inc. | $66.16M | $2.17 | — |
| ATHE | ALTERITY THERAPEUTICS LTD | $66.82M | $3.67 | — |
| GOSS | Gossamer Bio, Inc. | $66.85M | $10.94 | — |
News headlines (Yahoo Finance, 1h cache)
MindWalk (HYFT) Is Pivoting to Recurring AI Revenue. Can ReefIQ Offset Widening Losses?
2026-09-23 15:26 · Yahoo
MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine
2026-09-21 12:46 · Yahoo
MindWalk Holdings Corp (HYFT) (Q1 2027) Earnings Call Highlights: Revenue Climbs 21% as ReefIQ ...
2026-09-15 19:00 · Yahoo
MindWalk (HYFT) Q1 2027 Earnings Call Transcript
2026-09-15 14:01 · Yahoo
MindWalk Holdings Corp. Q1 2027 Earnings Call Summary
2026-09-15 12:30 · Yahoo
MindWalk Holdings Corp. (HYFT) Reports Q1 Loss, Misses Revenue Estimates
2026-09-14 22:05 · Yahoo
MindWalk Q1 Earnings Call Highlights
2026-09-14 22:03 · Yahoo
MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027
2026-09-14 20:56 · Yahoo
MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion
2026-09-14 12:46 · Yahoo
MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-10 12:34 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.